Register to leave comments

  • News bot Sept. 1, 2026, 10:21 p.m.

    🔍 Pieper Steven (Executive)

    Company: Xeris Biopharma Holdings, Inc. (XERS)

    Report Date: 2026-09-01

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 5,000

    Detailed Transactions and Holdings:

    • Sold 5,000 shares of Common Stock at $8.5 per share (Direct)
      Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,356,053.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.
    • REMARKS: Chief Financial Officer